Trade receivables increased 42.3%
Trade receivables changed +42.3% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Trade receivables changed +42.3% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Working capital changed +32.5% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Total assets changed +12.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating margin changed +1899 basis points from the comparable as-filed period.
Net income changed +163.4% from the comparable as-filed period.
Revenue changed +50.1% from the comparable as-filed period.
Gross margin changed +1397 basis points from the comparable as-filed period.
Research & development changed +33.5% from the comparable as-filed period.
Working capital / assets changed +340 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Inventory / revenue changed -1348 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Capex / revenue changed +333 basis points from the comparable as-filed period.
Gross profit changed +102.8% from the comparable as-filed period.
Current assets changed +28.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Inventory changed +26.8% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Operating cash flow changed +17.7% from the comparable as-filed period.
Operating income changed +1585.1% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Free-cash-flow proxy changed -9.9% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Stock-based compensation changed +36.3% from the comparable as-filed period.
Capital expenditure changed +186.5% from the comparable as-filed period.
Selling, general & administrative changed +41.4% from the comparable as-filed period.
Current liabilities changed +22.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Free-cash-flow margin changed -899 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash-flow margin changed -566 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Noncurrent long-term debt changed -26.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Operating cash flow / net income changed -55.3% from the comparable as-filed period.
R&D / revenue changed -273 basis points from the comparable as-filed period.
Receivables / revenue changed -344 basis points from the comparable as-filed period.
Shares outstanding changed +0.6% from the comparable as-filed period. The change ranks at the 75th percentile of 8 prior comparable changes.
Stockholders' equity changed +12.7% from the comparable as-filed period.
Cost of revenue changed +15.3% from the comparable as-filed period.
Cash & equivalents changed +14.5% from the comparable as-filed period.
SBC / revenue changed -44 basis points from the comparable as-filed period.
Current ratio changed +4.7% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.